| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Dec 29, 2023 | Option Exercise | $29.65 | 569 | 16,871 | 60,720 | Jan 03, 2024, 05:45 PM | |
| GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Dec 29, 2023 | Option Exercise | $2.36 | 5,827 | 13,752 | 20,244 | Jan 02, 2024, 04:05 PM | |
| IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Oct 30, 2023 | Option Exercise | $14.89 | 20,000 | 297,800 | 70,151 | Nov 01, 2023, 05:59 PM | |
| GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Sep 30, 2023 | Option Exercise | $1.50 | 9,167 | 13,751 | 14,417 | Oct 03, 2023, 04:15 PM | |
| IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Sep 29, 2023 | Option Exercise | $15.87 | 1,063 | 16,870 | 60,151 | Oct 02, 2023, 05:05 PM | |
| IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Jun 30, 2023 | Option Exercise | $18.87 | 894 | 16,870 | 59,088 | Jul 05, 2023, 05:53 PM | |
| IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Mar 31, 2023 | Option Exercise | $3.84 | 4,394 | 16,873 | 58,194 | Apr 04, 2023, 04:51 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Mar 03, 2022 | Buy | $59.98 | 5,000 | 299,900 | 10,812 | Mar 07, 2022, 04:05 PM | |
| IDRA | IDERA PHARMACEUTICALS, INC. | Goldberg Mark Alan | Director | Jan 04, 2021 | Option Exercise | $4.02 | 3,452 | 13,877 | 38,099 | Jan 06, 2021, 12:00 AM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Dec 24, 2020 | Option Exercise | $28.15 | 5,455 | 153,558 | 9,017 | Dec 28, 2020, 04:23 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Dec 24, 2020 | Sale | $125.00 | 5,455 | 681,875 | 3,562 | Dec 28, 2020, 04:23 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Dec 18, 2020 | Option Exercise | $28.15 | 5,454 | 153,530 | 9,016 | Dec 22, 2020, 04:14 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Dec 18, 2020 | Sale | $120.00 | 5,454 | 654,480 | 3,562 | Dec 22, 2020, 04:14 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Dec 11, 2020 | Option Exercise | $28.15 | 5,455 | 153,558 | 9,017 | Dec 15, 2020, 04:08 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Dec 11, 2020 | Sale | $115.00 | 5,455 | 627,325 | 3,562 | Dec 15, 2020, 04:08 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Dec 01, 2020 | Option Exercise | $28.15 | 5,454 | 153,530 | 9,016 | Dec 03, 2020, 04:10 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Dec 01, 2020 | Sale | $110.00 | 5,454 | 599,940 | 3,562 | Dec 03, 2020, 04:10 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Oct 19, 2020 | Option Exercise | $19.53 | 5,455 | 106,536 | 9,017 | Oct 21, 2020, 04:21 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Oct 19, 2020 | Sale | $105.00 | 5,455 | 572,775 | 3,562 | Oct 21, 2020, 04:21 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Oct 07, 2020 | Option Exercise | $19.53 | 5,454 | 106,517 | 9,016 | Oct 09, 2020, 04:04 PM | |
| BPMC | Blueprint Medicines Corp | Goldberg Mark Alan | Director | Oct 07, 2020 | Sale | $100.00 | 5,454 | 545,400 | 3,562 | Oct 09, 2020, 04:04 PM | |
| IDRA | IDERA PHARMACEUTICALS, INC. | Goldberg Mark Alan | Director | Oct 01, 2020 | Option Exercise | $2.25 | 6,166 | 13,874 | 34,647 | Oct 05, 2020, 04:06 PM | |
| IDRA | IDERA PHARMACEUTICALS, INC. | Goldberg Mark Alan | Director | Jul 01, 2020 | Option Exercise | $1.79 | 7,751 | 13,874 | 28,481 | Jul 02, 2020, 08:58 PM | |
| IDRA | IDERA PHARMACEUTICALS, INC. | Goldberg Mark Alan | Director | Apr 01, 2020 | Option Exercise | $1.28 | 10,730 | 13,734 | 20,730 | Apr 03, 2020, 05:19 PM | |
| BOLD | Audentes Therapeutics, Inc. | Goldberg Mark Alan | Director | Jan 15, 2020 | Option Exercise | $60.00 | 1,500 | 90,000 | 0 | Jan 15, 2020, 01:27 PM | |
| IDRA | IDERA PHARMACEUTICALS, INC. | Goldberg Mark Alan | Director | Dec 19, 2018 | Buy | $3.19 | 10,000 | 31,897 | 10,000 | Dec 20, 2018, 05:26 PM | |
| IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Nov 06, 2018 | Buy | $5.76 | 30,000 | 172,800 | 53,800 | Nov 07, 2018, 09:54 AM | |
| IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Dec 15, 2016 | Buy | $1.80 | 20,000 | 36,000 | 23,800 | Dec 15, 2016, 11:51 AM | |
| GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Mar 04, 2016 | Buy | $4.77 | 10,397 | 49,630 | 11,497 | Mar 07, 2016, 08:03 AM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 19, 2014 | Option Exercise | $8.73 | 790 | 6,897 | 1,352 | Sep 19, 2014, 05:56 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 19, 2014 | Sale | $65.24 | 790 | 51,540 | 562 | Sep 19, 2014, 05:56 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 17, 2014 | Option Exercise | $8.73 | 4,200 | 36,666 | 4,762 | Sep 18, 2014, 05:21 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 17, 2014 | Sale | $65.06 | 4,200 | 273,252 | 562 | Sep 18, 2014, 05:21 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 16, 2014 | Option Exercise | $8.73 | 9,379 | 81,879 | 9,941 | Sep 18, 2014, 05:21 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Sep 16, 2014 | Sale | $65.01 | 9,379 | 609,729 | 562 | Sep 18, 2014, 05:21 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Jun 30, 2014 | Option Exercise | $54.89 | 103 | 5,654 | 562 | Jul 02, 2014, 05:56 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Jun 11, 2014 | Option Exercise | $7.66 | 21,597 | 165,513 | 22,056 | Jun 12, 2014, 05:07 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Jun 11, 2014 | Sale | $80.00 | 21,597 | 1,727,760 | 459 | Jun 12, 2014, 05:07 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | EVP, Medical & Reg. Strategy | Dec 31, 2013 | Option Exercise | $36.30 | 192 | 6,970 | 459 | Jan 02, 2014, 07:07 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Dec 02, 2013 | Option Exercise | $8.73 | 7,000 | 61,110 | 7,267 | Dec 04, 2013, 05:07 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Dec 03, 2013 | Sale | $60.52 | 7,000 | 423,649 | 680 | Dec 04, 2013, 05:07 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Nov 01, 2013 | Option Exercise | $8.73 | 7,000 | 61,110 | 7,267 | Nov 04, 2013, 05:35 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Nov 01, 2013 | Sale | $49.96 | 7,000 | 349,753 | 3,572 | Nov 04, 2013, 05:35 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Oct 01, 2013 | Option Exercise | $8.73 | 7,000 | 61,110 | 7,267 | Oct 03, 2013, 04:07 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Oct 01, 2013 | Sale | $64.31 | 7,000 | 450,203 | 4,037 | Oct 03, 2013, 04:07 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Jun 28, 2013 | Option Exercise | $35.68 | 267 | 9,527 | 267 | Jul 01, 2013, 05:07 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Apr 01, 2013 | Option Exercise | $0.95 | 4,416 | 4,195 | 4,416 | Apr 03, 2013, 10:21 AM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP,Medical&Regulatory Affairs | Apr 01, 2013 | Sale | $54.31 | 4,416 | 239,831 | 619 | Apr 03, 2013, 10:21 AM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP, Product Development | Mar 01, 2013 | Option Exercise | $0.95 | 4,417 | 4,196 | 4,417 | Mar 06, 2013, 06:00 AM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP, Product Development | Mar 01, 2013 | Sale | $50.76 | 4,417 | 224,217 | 1,713 | Mar 06, 2013, 06:00 AM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP, Product Development | Feb 01, 2013 | Sale | $47.75 | 4,417 | 210,892 | 2,660 | Feb 05, 2013, 05:35 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP, Product Development | Feb 01, 2013 | Option Exercise | $0.95 | 4,417 | 4,196 | 4,417 | Feb 05, 2013, 05:35 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP, Product Development | Jan 02, 2013 | Option Exercise | $0.95 | 4,417 | 4,196 | 4,417 | Jan 04, 2013, 04:30 PM | |
| GEVA | SYNAGEVA BIOPHARMA CORP | Goldberg Mark Alan | SVP, Product Development | Jan 02, 2013 | Sale | $47.52 | 4,417 | 209,896 | 0 | Jan 04, 2013, 04:30 PM | |
| IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Nov 08, 2012 | Buy | $11.27 | 3,000 | 33,804 | 3,800 | Nov 09, 2012, 11:06 AM |
Menu